Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin

por Dobbins, Robert, Hussey, Elizabeth K., O’Connor-Semmes, Robin, Andrews, Susan, Tao, Wenli, Wilkison, William O., Cheatham, Bentley, Sagar, Katare, Hanmant, Barkate
Publicado 2021